Saturday, July 11, 2026

Drug profile · INN

tegomil fumarate

tegomil fumarate (RIULVY) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Antineoplastic and immunomodulating agents (L04) L04AX10
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — tegomil fumarate
Class
Antineoplastic and immunomodulating agents (L04)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

tegomil fumarate (RIULVY) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tegomil fumarate
Brand RIULVY
Therapeutic class Antineoplastic and immunomodulating agents (L04)
ATC code L04AX10

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. NXPTEGO/23/P1-4 Phase 1 · NEURAXPHARM AUSTRALIA PTY · Multiple Sclerosis

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. anagrelide Antineoplastic and immunomodulating agents (L01)
  3. apremilast Antineoplastic and immunomodulating agents (L04)
  4. arsenic trioxide Antineoplastic and immunomodulating agents (L01)
  5. axitinib Antineoplastic and immunomodulating agents (L01)
  6. azacitidine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is tegomil fumarate?

tegomil fumarate (RIULVY) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for tegomil fumarate?

RIULVY is a marketed brand name for tegomil fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.